antiretroviral - search results

Do we need new antiretroviral drugs to treat HIV infection, and if so, what are the promising targets? Dr Eric O. Freed, Director of the HIV Dynamics and Replication Program at the National Cancer Institute in Frederick, Maryland, discusses these questions.

Researchers aim to uncover how extreme weather affects long-term HIV care outcomes and implications for addressing climate change impacts and other chronic health conditions.

Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, explains that we need stronger efforts worldwide to end HIV transmission and improve the lives of those living with the disease.

An urban gardening program has received $3.4 million to reduce food insecurity in the Dominican Republic – and was also found to greatly improve HIV outcomes.

Dr. Eric O. Freed received his Ph.D. in 1990 from the University of Wisconsin-Madison His Ph.D. work focused on the function of the murine leukemia virus and HIV envelope glycoproteins in membrane fusion and virus entry. He joined the National Institute of Allergy and Infectious Diseases (NIAID) at the NIH...

Here, Professor of Epidemiology & International Health Richard Hayes explores and details the PopART study and other trials of Universal Testing and Treatment, a promising strategy to reduce HIV spread.

Dr Zisis Kozlakidis and Sandra Nanyonga discuss public health strategies, then and now, with a focus on the prevalence of STDs.

Scientists at AIDS 2022 describe how new technological insights into HIV latent cells could help HIV cure research.

The WHO have new treatment guidelines for cryptococcal meningitis in people living with HIV - a single high dose of liposomal amphotericin B.

The first ever woman cured from HIV underwent a dual stem-cell transplant, which seems to have made her genetically resistant to HIV and put her cancer into remission.

Global COVID-19 responses could serve as a coordinated approach to end the HIV pandemic - bettering global immunisation to both viruses.

After receiving a cord blood stem cell transplant to treat acute myeloid leukaemia a woman with diagnosed HIV has had no detectable levels of HIV for 14 months

December saw monumental steps being taken in HIV prevention with the FDA approving their first approval of long-acting HIV prevention medication.

A new study on HIV medication treatment discovered persistent disparities between sex and age, potentially subjecting women to worse HIV treatment outcomes on the drug dolutegravir.

With 7.5 million people living with HIV, how has climate change and COVID-19 affected the South African governments control over the AIDS crisis and which demographics have been hit the hardest?

Research by the American Heart Association found that people with HIV are more likely to experience heart attacks - with "higher rates of sudden cardiac death".

The REACH study found that 97% of women and girls in Uganda, South Africa and Zimbabwe are happy to work with HIV prevention methods - globally, half of all people living with HIV are women.

Dr Deborah Lee, Dr Fox Online Pharmacy, tells us all about hyperpigmentation including the different types, the causes and the treatment options.

The team will have results to discuss in April, 2022 - they nurse the hope that this HIV vaccine could stop different geographical strains, after 40 years of no cure.

In a new study, researchers have found that individuals living with HIV and AIDS have an increased risk of death from COVID-19 infection.